Effect of Preoperative Silodosin on Feasibility of Ureteral Access Sheath Insertion
Recruiting
N/A
Interventional Study
Renal Stone
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 2,000 (estimated)
- Sponsor
- Al-Azhar University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The ureteral access sheath (UAS) is an ancillary device widely used by urologists to facilitate fast, repeatable, and safe access to ureters and collecting systems; improve visibility; reduce the risk of infection by reducing intrarenal pressure; and protect ureters and scopes when extracting multiple stones during surgery.
Insertion of ureteric access sheath may be difficult due to tight ureter,…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* All patients with renal stones who will undergo flexible ureteroscopy and planned for using ureteral access sheath
Exclusion Criteria:
* Paediatric age group (less than 18 year)
Contacts
No contact information available.